These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 27678182)

  • 1. An update on interventional cardiology: management of CTO, performance of absorbable scaffolds, coronary vasomotion after DES, and antithrombotics.
    Lüscher TF
    Eur Heart J; 2016 Sep; 37(35):2681-3. PubMed ID: 27678182
    [No Abstract]   [Full Text] [Related]  

  • 2. Everolimus-eluting bioresorbable vascular scaffolds versus second generation drug-eluting stents for percutaneous treatment of chronic total coronary occlusions: Technical and procedural outcomes from the GHOST-CTO registry.
    La Manna A; Chisari A; Giacchi G; Capodanno D; Longo G; Di Silvestro M; Capranzano P; Tamburino C
    Catheter Cardiovasc Interv; 2016 Nov; 88(6):E155-E163. PubMed ID: 26756959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the Safety of Everolimus-Eluting Bioresorbable Vascular Scaffold (BVS) Implantation in Patients With Chronic Total Coronary Occlusions: Acute Procedural and Short-Term Clinical Results.
    Goktekin O; Yamac AH; Latib A; Tastan A; Panoulas VF; Sato K; Erdogan E; Uyarel H; Shah I; Colombo A
    J Invasive Cardiol; 2015 Oct; 27(10):461-6. PubMed ID: 26429848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hybrid ABSORB bioresorbable vascular scaffold and drug eluting stent or hybrid BVS-DES percutaneous coronary intervention: Method and rationale for hybrid overlapping PCI.
    Yew KL
    Int J Cardiol; 2015; 186():74-6. PubMed ID: 25814348
    [No Abstract]   [Full Text] [Related]  

  • 5. Contemporary techniques for coronary CTO revascularization.
    Dedovic V; Stankovic G
    Panminerva Med; 2015 Mar; 57(1):15-27. PubMed ID: 25371142
    [No Abstract]   [Full Text] [Related]  

  • 6. Vascular response and healing profile of everolimus-eluting bioresorbable vascular scaffolds for percutaneous treatment of chronic total coronary occlusions: A one-year optical coherence tomography analysis from the GHOST-CTO registry.
    La Manna A; Miccichè E; D'Agosta G; Tensol Rodrigues Pereira G; Attizzani GF; Capranzano P; Capodanno D; Tamburino C
    Int J Cardiol; 2018 Feb; 253():45-49. PubMed ID: 29137819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioresorbable scaffolds: the fee comes now and the reward comes later.
    Jabbour RJ; Colombo A
    Future Cardiol; 2016 Jul; 12(4):397-400. PubMed ID: 27291396
    [No Abstract]   [Full Text] [Related]  

  • 8. Bioresorbable vascular scaffolds in coronary chronic total occlusions revascularization: safety assessment related to struts coverage and apposition in 6-month OCT follow-up.
    Abellas-Sequeiros RA; Ocaranza-Sanchez R; Trillo-Nouche R; Gonzalez-Juanatey C; Gonzalez-Juanatey JR
    Heart Vessels; 2017 Sep; 32(9):1077-1084. PubMed ID: 28432385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subacute recoil in bioresorbable vascular scaffold in a complex coronary lesion: A lesson from daily clinical practice.
    Centola M; Lucreziotti S; Salerno-Uriarte D; Tresoldi S; Cannone G; Sponzilli C; Carugo S
    Int J Cardiol; 2016 Jan; 203():995-6. PubMed ID: 26625328
    [No Abstract]   [Full Text] [Related]  

  • 10. No more metallic cages: an attractive hybrid strategy with bioresorbable vascular scaffold and drug-eluting balloon for diffuse or tandem lesions in the same vessel.
    Naganuma T; Latib A; Ielasi A; Panoulas VF; Sato K; Miyazaki T; Colombo A
    Int J Cardiol; 2014 Apr; 172(3):618-9. PubMed ID: 24495653
    [No Abstract]   [Full Text] [Related]  

  • 11. Percutaneous coronary intervention for chronic total occlusion of the coronary artery with the implantation of bioresorbable everolimus-eluting scaffolds. Poznan CTO-Absorb Pilot Registry.
    Lesiak M; Łanocha M; Araszkiewicz A; Siniawski A; Grygier M; Pyda M; Olasińska-Wiśniewska A; Iwanczyk S; Skorupski W; Mitkowski P; Lesiak MB; Grajek S
    EuroIntervention; 2016 Jun; 12(2):e144-51. PubMed ID: 27290673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed coverage of drug-eluting stents after interventional revascularisation of chronic total occlusions assessed by optical coherence tomography: the ALSTER-OCT-CTO registry.
    Heeger CH; Busjahn A; Hildebrand L; Fenski M; Lesche F; Meincke F; Kuck KH; Bergmann MW
    EuroIntervention; 2016 Jan; 11(9):1004-12. PubMed ID: 25287264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positive Vessel Remodeling and Appearance of Pulsatile Wall Motion at Long-Term Follow-Up After Bioresorbable Scaffold Implantation in a Chronic Total Occlusion.
    Tanaka A; Ruparelia N; Kawamoto H; Latib A; Colombo A
    JACC Cardiovasc Interv; 2015 Oct; 8(12):1635-7. PubMed ID: 26386767
    [No Abstract]   [Full Text] [Related]  

  • 14. [Absorb BVS: quo vadis?].
    Brugaletta S; Pernigotti A
    G Ital Cardiol (Rome); 2016 Oct; 17(10 Suppl 1):45S-46. PubMed ID: 27729668
    [No Abstract]   [Full Text] [Related]  

  • 15. Three-year clinical outcome after treatment of chronic total occlusions with second-generation drug-eluting stents in the TWENTE trial.
    van Houwelingen KG; Sen H; Lam MK; Tandjung K; Löwik MM; de Man FH; Louwerenburg JH; Stoel MG; Hartmann M; Linssen GC; Doggen CJ; von Birgelen C
    Catheter Cardiovasc Interv; 2015 Feb; 85(3):E76-82. PubMed ID: 25339110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Everolimus-eluting bioresorbable vascular scaffolds for treatment of complex chronic total occlusions.
    Fam JM; Ojeda S; Garbo R; Latib A; La Manna A; Vaquerizo B; Boukhris M; Vlachojannis GJ; van Geuns RJ; Ezhumalai B; Kawamoto H; van der Sijde J; Felix C; Pan M; Serdoz R; Boccuzzi GG; De Paolis M; Sardella G; Mancone M; Tamburino C; Smits PC; Di Mario C; Seth A; Serra A; Colombo A; Serruys P; Galassi AR; Zijlstra F; Van Mieghem NM; Diletti R
    EuroIntervention; 2017 Jun; 13(3):355-363. PubMed ID: 28218604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic total occlusion is associated with a higher incidence of malapposition and uncovered stent struts: OCT findings at 6 months following DES implantation.
    Jia H; Hu S; Liu H; Zhu Y; Zhe CY; Li L; Mustafina I; Hou J; Zhang S; Yu B
    Catheter Cardiovasc Interv; 2017 Mar; 89(S1):582-591. PubMed ID: 28318139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new generation of drug-eluting stents: Indications and outcomes of bioresorbable vascular scaffolds.
    Waksman R
    Cleve Clin J Med; 2017 Dec; 84(12 Suppl 4):e20-e24. PubMed ID: 29281608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of everolimus- and biolimus-eluting coronary stents with everolimus-eluting bioresorbable vascular scaffolds.
    Puricel S; Arroyo D; Corpataux N; Baeriswyl G; Lehmann S; Kallinikou Z; Muller O; Allard L; Stauffer JC; Togni M; Goy JJ; Cook S
    J Am Coll Cardiol; 2015 Mar; 65(8):791-801. PubMed ID: 25720622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug eluting stent and coronary chronic total occlusions.
    Niccoli G; Leo A; Giubilato S; Cosentino N; Minelli S; Galiffa VA; Crea F
    Minerva Cardioangiol; 2011 Jun; 59(3):271-84. PubMed ID: 21516075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.